Nigeria: Covid-19 Vaccines Produced in Nigeria Will Meet International Standards - NAFDAC

United States News News

Nigeria: Covid-19 Vaccines Produced in Nigeria Will Meet International Standards - NAFDAC
United States Latest News,United States Headlines
  • 📰 allafrica
  • ⏱ Reading Time:
  • 29 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 99%

Covid-19 Vaccines Produced in Nigeria Will Meet International Standards - NAFDAC vanguardngrnews: Nigeria Coronavirus Covid19

The Director General, Prof. Mojisola Adeyeye who asserted during the oversight visit to the NAFDAC facilities and COVID-19 laboratory projects in Lagos by the House of Representatives Committee on COVID-19 weekend described the Federal government's huge spending on the fight against COVID-19 as demonstrated by the construction of the new COVID-19 laboratory with modern instruments and amenities as a wake-up call for the country.

"We have the African Free trade Agreement already here with us now for the nation's pharmaceutical industry to take advantage of with quality products. There will be a lot of competition and if NAFDAC's laboratory is not strengthened, we will not be able to compete". With NAFDAC now very strong with WHO Maturity Level 3 certification, Prof Mojisola Adeyeye enthused that"Nigeria can now make her vaccines and we can assure the populace that there is quality in whatever is being manufactured because of NAFDAC's strength".

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

allafrica /  🏆 1. in ZA

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Moderna sues Pfizer after saying it wouldn't enforce its patents for Covid-19 vaccine technology | BusinessinsiderModerna sues Pfizer after saying it wouldn't enforce its patents for Covid-19 vaccine technology | BusinessinsiderModerna is suing competing vaccine maker Pfizer and its German partner BioNTech, alleging the pharmaceutical companies copied its technology.
Read more »

Moderna sues Pfizer, BioNTech for Covid-19 vaccine patent infringementModerna sues Pfizer, BioNTech for Covid-19 vaccine patent infringementModerna said Friday it is suing rival vaccine makers Pfizer and BioNTech, alleging the partners infringed on its patents in developing their Covid-19 shot administered to hundreds of millions around the world.
Read more »

Newsdeck: Moderna sues Pfizer/BioNTech for patent infringement over Covid-19 vaccineNewsdeck: Moderna sues Pfizer/BioNTech for patent infringement over Covid-19 vaccineAug 26 (Reuters) - Moderna is suing Pfizer and its German partner BioNTech for patent infringement in the development of the first Covid-19 vaccine approved in the United States, alleging they copied technology that Moderna developed years before the pandemic.
Read more »

Moderna sues Pfizer-BioNTech over Covid-19 vaccine technologyModerna alleges Pfizer-BioNTech, without permission, copied mRNA technology Moderna had patented between 2010 and 2016
Read more »

Qantas CEO says the airline received 25 000 job applications for 2 500 roles | BusinessinsiderQantas CEO says the airline received 25 000 job applications for 2 500 roles | BusinessinsiderAlan Joyce said sickness rates due to Covid-19 were behind Qantas' operational problems, rather than a labour shortage.
Read more »



Render Time: 2025-03-04 17:28:27